RecruitingLiver Diseases
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.
Sponsor: University of Chicago
You may qualify if…
- ✓ Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated
You may not qualify if…
- ✕ \<18 yrs. of age
Where it's recruiting
Illinois
Chicago
Source: ClinicalTrials.gov · NCT05264051 · last updated 2026-01-14